Fredrik Erixon

Fredrik Erixon is a Swedish economist and writer. He has been the Director of the European Centre for International Political Economy (ECIPE) ever since its start in 2006. The Financial Times has ranked Erixon as one of Brussels 30 most influential people.

Fredrik Erixon is the author of several books and studies in the fields of international economics, economic policy, and regulatory affairs (welfare reforms, healthcare, competition policy, et cetera). His latest book (co-authored with Björn Weigel) was The Innovation Illusion: How so Little is Created by so Many Working so Hard (Yale University Press) and he has previously written books about the history of political ideas, the role of social capital for economic growth, and international economic policy. His research interests covers international economics, European relations with Asia and North America, trade and regulatory policy, philosophy and technological change. His next book, Saving Liberalism for the 21st Century, is about challenges from populism and other ideas to the open society.

Erixon has advised several governments in Europe and the rest of the world and is a frequent speaker at conferences. He regularly writes for international newspapers and magazines. In his previous career, Erixon has worked in development policy, financial markets, business consulting, and academia.

Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox

By Sujai Shivakumar and Anne Pritchett The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as “global freeloading” and to ensure U.S. patients pay prices comparable to those in other developed nations. The administration argues that while the United States represents less than 5 percent
Read More

Universities, Patents, and the Future of U.S. Competitiveness

By Shruti Sharma and Chris Borges Universities are among the most powerful engines of U.S. innovation, transforming federal research investments into scientific discoveries that underpin economic growth, technological leadership, and national security. Current law, via the Bayh-Dole Act, allows universities to patent inventions and license them to private companies, with royalties
Read More

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More